Education
About Us
Working with TipRanks
Follow Us
IXICO PLC (GB:IXI)
LSE:IXI
IXI Stock Chart & Stats
Day’s Range― - ―
52-Week Range7.35p - 15.00p
Previous CloseN/A
Volume22.18K
Average Volume (3M)58.73K
Market Cap
£11.35M
Enterprise Value2.38M
Total Cash (Recent Filing)£1.79M
Total Debt (Recent Filing)£314.00K
Price to Earnings (P/E)―
Beta1.12
Next Earnings
Dec 03, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding92,668,594
10 Day Avg. Volume30,033
30 Day Avg. Volume58,729
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£13.00Price Target Upside6.12% Upside
Rating ConsensusHold
Number of Analyst Covering0
IXICO plc News
IXI FAQ
What was IXICO PLC’s price range in the past 12 months?
IXICO PLC lowest share price was 7.35p and its highest was 15.00p in the past 12 months.
What is IXICO PLC’s market cap?
IXICO PLC’s market cap is £11.35M.
When is IXICO PLC’s upcoming earnings report date?
IXICO PLC’s upcoming earnings report date is Dec 03, 2025 which is in 102 days.
How were IXICO PLC’s earnings last quarter?
Currently, no data Available
Is IXICO PLC overvalued?
According to Wall Street analysts IXICO PLC’s price is currently Undervalued.
Does IXICO PLC pay dividends?
IXICO PLC does not currently pay dividends.
What is IXICO PLC’s EPS estimate?
IXICO PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IXICO PLC have?
IXICO PLC has 92,668,594 shares outstanding.
What happened to IXICO PLC’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of IXICO PLC?
Currently, no hedge funds are holding shares in GB:IXI
Company Description
IXICO PLC
IXICO plc (IXI) is a technology-enabled healthcare company specializing in the delivery of advanced imaging and data analytics services to the pharmaceutical and biotechnology sectors. The company focuses on supporting clinical trials and research, particularly in neurology, by providing insights derived from medical imaging and other data sources. IXICO's core services include imaging biomarker analysis, data management, and software solutions that enhance the efficiency and effectiveness of drug development processes.
IXICO plc (IXI) Earnings & Revenues
Currently, no data available
Please return soon. This page is being updated.
Technical Analysis
Ownership Overview
1.41% Insiders
―
Mutual Funds
― Other Institutional Investors
98.59% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---